Jeffs Roger insider trades
Jeffs Roger has filed 52 Form 4s with the SEC that we hold, for Liquidia Corp (LQDA) (Chief Executive Officer, Director) and Axsome Therapeutics, Inc. (AXSM) (Director). Across all of them we count 5 purchases worth $1.5M and 47 sales worth $49.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 29 sales ($31.9M). The largest single trade was a sale of 66,610 shares of Liquidia Corp worth $2.5M, dated 2026-01-12. The first filing on our record is dated 2021-09-01 and the latest 2026-07-14.
Liquidia Corp (LQDA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-24 | P, purchase reported on Form 4 | 28,000 | $98.8K | 2022-05-25 |
| 2022-08-31 | P, purchase reported on Form 4 | 993 | $4.9K | 2022-09-01 |
| 2022-09-06 | P, purchase reported on Form 4 | 43,820 | $244.1K | 2022-09-07 |
| 2023-12-14 | P, purchase reported on Form 4 | 139,665 | $1.0M | 2023-12-18 |
| 2024-03-18 | S, sale reported on Form 4 | 28,583 | $452.2K | 2024-03-19 |
| 2024-04-12 | S, sale reported on Form 4 | 8,360 | $121.9K | 2024-04-16 |
| 2024-07-12 | S, sale reported on Form 4 | 8,053 | $100.9K | 2024-07-15 |
| 2024-10-14 | S, sale reported on Form 4 | 8,053 | $89.5K | 2024-10-15 |
| 2025-01-14 | S, sale reported on Form 4 | 22,343 | $263.2K | 2025-01-14 |
| 2025-04-14 | S, sale reported on Form 4 | 14,130 | $191.7K | 2025-04-16 |
| 2025-06-04 | S, sale reported on Form 4 | 30,610 | $519.5K | 2025-06-05 |
| 2025-07-14 | S, sale reported on Form 4 | 20,252 | $289.2K | 2025-07-15 |
| 2025-07-14 | S, sale reported on Form 4 | 20,252 | $289.2K | 2025-07-15 |
| 2025-10-13 | S, sale reported on Form 4 | 20,261 | $474.3K | 2025-10-15 |
| 2026-01-12 | S, sale reported on Form 4 | 66,610 | $2.5M | 2026-01-13 |
| 2026-04-09 | S, sale reported on Form 4 | 25,000 | $1.0M | 2026-04-13 |
| 2026-04-10 | S, sale reported on Form 4 | 21,433 | $859.9K | 2026-04-14 |
| 2026-04-13 | S, sale reported on Form 4 | 32,744 | $1.3M | 2026-04-14 |
| 2026-04-14 | S, sale reported on Form 4 | 3,300 | $132.0K | 2026-04-16 |
| 2026-04-15 | S, sale reported on Form 4 | 25,000 | $1.0M | 2026-04-16 |
| 2026-04-16 | S, sale reported on Form 4 | 25,000 | $1.0M | 2026-04-16 |
| 2026-04-17 | S, sale reported on Form 4 | 18,839 | $764.9K | 2026-04-21 |
| 2026-05-05 | S, sale reported on Form 4 | 25,000 | $1.0M | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 25,000 | $1.0M | 2026-05-07 |
| 2026-05-07 | S, sale reported on Form 4 | 25,000 | $1.1M | 2026-05-07 |
| 2026-05-08 | S, sale reported on Form 4 | 25,000 | $1.1M | 2026-05-12 |
| 2026-05-11 | S, sale reported on Form 4 | 25,000 | $1.0M | 2026-05-12 |
| 2026-05-12 | S, sale reported on Form 4 | 25,000 | $1.4M | 2026-05-12 |
| 2026-05-13 | S, sale reported on Form 4 | 25,000 | $1.4M | 2026-05-15 |
| 2026-05-14 | S, sale reported on Form 4 | 25,000 | $1.5M | 2026-05-15 |
| 2026-05-15 | S, sale reported on Form 4 | 25,000 | $1.4M | 2026-05-15 |
| 2026-05-18 | S, sale reported on Form 4 | 25,000 | $1.4M | 2026-05-20 |
| 2026-05-19 | S, sale reported on Form 4 | 25,000 | $1.5M | 2026-05-20 |
| 2026-05-20 | S, sale reported on Form 4 | 25,000 | $1.5M | 2026-05-20 |
| 2026-05-21 | S, sale reported on Form 4 | 25,000 | $1.5M | 2026-05-26 |
| 2026-05-22 | S, sale reported on Form 4 | 25,000 | $1.5M | 2026-05-26 |
| 2026-05-26 | S, sale reported on Form 4 | 25,000 | $1.5M | 2026-05-26 |
| 2026-05-27 | S, sale reported on Form 4 | 6,428 | $399.7K | 2026-05-28 |
| 2026-07-13 | S, sale reported on Form 4 | 2,505 | $178.8K | 2026-07-14 |
| 2026-07-13 | S, sale reported on Form 4 | 32,744 | $2.3M | 2026-07-14 |
Axsome Therapeutics, Inc. (AXSM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-19 | P, purchase reported on Form 4 | 3,950 | $147.3K | 2021-11-23 |
| 2024-03-14 | S, sale reported on Form 4 | 13,000 | $906.1K | 2024-03-15 |
| 2024-03-14 | S, sale reported on Form 4 | 16,976 | $1.2M | 2024-03-15 |
| 2024-03-15 | S, sale reported on Form 4 | 2,347 | $168.1K | 2024-03-15 |
| 2025-08-22 | S, sale reported on Form 4 | 16,694 | $2.0M | 2025-08-26 |
| 2025-08-26 | S, sale reported on Form 4 | 20,000 | $2.4M | 2025-08-26 |
| 2025-08-27 | S, sale reported on Form 4 | 20,000 | $2.4M | 2025-08-29 |
| 2025-08-28 | S, sale reported on Form 4 | 20,000 | $2.4M | 2025-08-29 |
| 2025-08-29 | S, sale reported on Form 4 | 20,000 | $2.4M | 2025-08-29 |
| 2025-09-02 | S, sale reported on Form 4 | 13,464 | $1.7M | 2025-09-02 |
| 2026-06-10 | S, sale reported on Form 4 | 286 | $70.4K | 2026-06-11 |
| 2026-06-11 | S, sale reported on Form 4 | 286 | $71.2K | 2026-06-11 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1231615) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms